Key Square Capital Management’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
EIP
Key Square Capital Management's CLB Position: Q2 2018 in Review
Key Square Capital Management sold out of Core Laboratories (CLB) in Q2 2018, closing a stake of 53,968 shares — an estimated $5.84M sold.
Key Square Capital Management first reported a position in CLB in Q4 2017 and held it in 2 quarters. The position peaked at $6.55M in Q4 2017. 374 funds tracked by Wall St. Rank hold CLB as of Q2 2018.
- Key Square Capital Management reported no remaining Core Laboratories position as of Q2 2018 after selling out during the quarter.
- Key Square Capital Management sold 53,968 Core Laboratories shares in Q2 2018, an estimated $5.84M.
- Key Square Capital Management first reported a position in Core Laboratories in Q4 2017 and held it in 2 quarters.
- Key Square Capital Management's Core Laboratories position peaked at $6.55M in Q4 2017.
- 374 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2018.
Based on Key Square Capital Management's 13F filing for Q2 2018, filed 10 Aug 2018.